Compound News and Research

RSS

Injecting vaccine-like compound into mice effective in protecting from malaria

A study led by Johns Hopkins Bloomberg School of Public Health researchers found that injecting a vaccine-like compound into mice was effective in protecting them from malaria.

12 Aug 2014

New method could make cashews safer for people with allergies

For the millions of adults and children in the U.S. who have to shun nuts to avoid an allergic reaction, help could be on the way. Scientists are now developing a method to process cashews - and potentially other nuts - that could make them safer to eat for people who are allergic to them.

11 Aug 2014

Exposure of pregnant women and fetuses to antibacterial compounds leads to health risk

As the Food and Drug Administration (FDA) mulls over whether to rein in the use of common antibacterial compounds that are causing growing concern among environmental health experts, scientists are reporting today that many pregnant women and their fetuses are being exposed to these substances.

11 Aug 2014

Researchers discover cardiac molecule that could provide key to treating, preventing heart failure

Researchers have discovered a previously unknown cardiac molecule that could provide a key to treating, and preventing, heart failure.

11 Aug 2014

Dermatologist warns about safety of children's skin care products

Before the advent of Internet search engines, parents obtained much of their medical advice from their child's doctor.

8 Aug 2014

Dimethyl fumarate offers no added benefits for adults with RRMS

Dimethyl fumarate has been approved since January 2014 for adults with relapsing remitting multiple sclerosis.

8 Aug 2014

Soligenix demonstrates improved immunogenicity and rapid action of anthrax vaccine, VeloThrax

Soligenix, Inc., a clinical stage biopharmaceutical company focused on developing products to treat serious inflammatory diseases where there remains an unmet medical need, as well as developing several biodefense vaccines and therapeutics, announced today results demonstrating the improved immunogenicity and rapid action of its anthrax vaccine, VeloThrax™.

7 Aug 2014

Altering the circadian rhythm: an interview with Dr. Doug Kojetin, The Scripps Research Institute

The circadian rhythm is affected by many different stimuli—such as sleep and light, which are the most broadly appreciated ways—but also eating— all of which can modulate, or change, important processes in our bodies such as temperature, production of hormones or other signalling small molecules, cellular regeneration, and others.

6 Aug 2014

Study investigates value of Pre-Exhaustion training method

A new study just published in the journal Applied Physiology, Nutrition, and Metabolism investigated the value of the Pre-Exhaustion (PreEx) training method and found that that the various arrangements of different exercise protocols is of less relevance than simply performing resistance training exercises with a high intensity of effort within any protocol.

6 Aug 2014

High levels of pervasive chemical in women may lead to adverse effects in offspring

In some women abnormally high levels of a common and pervasive chemical may lead to adverse effects in their offspring.

6 Aug 2014

Study: Compound Formula Rehmannia reduces levodopa-induced dyskinesia in Parkinson's disease

Levodopa is the preferred treatment for Parkinson's disease in the clinic. However, long-term use of levodopa may lead to various motor complications, among which levodopa-induced dyskinesia is the most common, severely affecting patients' quality of life.

5 Aug 2014

Researchers one step closer to finding treatment for dengue fever

There have been several news reports that the world's first dengue vaccine will be available next year. However, the latest clinical trials show that the vaccine only provides a protection of around 50 per cent for DENV-2 and DENV-1, which are commonly found in Singapore.

1 Aug 2014

Botanical Dietary Supplement Screening using NMR and MS

An interview with Kim Colson from Bruker Biospin, discussing the applications of NMR and mass spectrometry in the field of botanical science.

From Bruker BioSpin Division 1 Aug 2014

Catylix, Aspira Scientific partner to develop and commercialize new fluorination products

Catylix, Inc. (Burbank, California) and Aspira Scientific (Milpitas, California) announced today the formation of a joint venture to develop and commercialize new fluorination products and related chemistry.

31 Jul 2014

CardioNova initiates Phase 1b clinical trial with AtheroNova's AHRO-001

AtheroNova Inc., a biotech company focused on the research and development of compounds to safely regress atherosclerotic plaque and improve lipid profiles in humans, today announces that its partner, CardioNova, has accomplished first dosing of subjects for its Phase 1b clinical trial with AtheroNova's lead compound, AHRO-001.

30 Jul 2014

EMD Serono begins MSB0010718C Phase II study in mMCC patients

EMD Serono, Inc., a subsidiary of Merck KGaA, Darmstadt, Germany, today announced the initiation of an international Phase II study designed to assess the efficacy and safety of MSB0010718C, an investigational fully human IgG1 monoclonal antibody that binds to programmed death-ligand 1 (PD-L1).

29 Jul 2014

Researchers find molecule that irreversibly interferes with activity of mutated cancer gene

UT Southwestern Medical Center cancer researchers have found a molecule that selectively and irreversibly interferes with the activity of a mutated cancer gene common in 30 percent of tumors.

29 Jul 2014

EMA CHMP adopts positive opinion for Janssen’s IMBRUVICA to treat CLL and MCL

Janssen-Cilag International NV announced today that the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion recommending the granting of a marketing authorisation for IMBRUVICA (ibrutinib) in the European Union.

29 Jul 2014

Researchers one step closer to finding treatment for Alzheimer's, other forms of dementia

There is no cure for Alzheimer's disease and other forms of dementia, but the research community is one step closer to finding treatment.

29 Jul 2014

Cancer researchers find molecule that irreversibly interferes with KRAS gene

UT Southwestern Medical Center cancer researchers have found a molecule that selectively and irreversibly interferes with the activity of a mutated cancer gene common in 30 percent of tumors.

29 Jul 2014

Compound News and Research

Injecting vaccine-like compound into mice effective in protecting from malaria

New method could make cashews safer for people with allergies

Exposure of pregnant women and fetuses to antibacterial compounds leads to health risk

Researchers discover cardiac molecule that could provide key to treating, preventing heart failure

Dermatologist warns about safety of children's skin care products

Dimethyl fumarate offers no added benefits for adults with RRMS

Soligenix demonstrates improved immunogenicity and rapid action of anthrax vaccine, VeloThrax

Altering the circadian rhythm: an interview with Dr. Doug Kojetin, The Scripps Research Institute

Study investigates value of Pre-Exhaustion training method

High levels of pervasive chemical in women may lead to adverse effects in offspring

Study: Compound Formula Rehmannia reduces levodopa-induced dyskinesia in Parkinson's disease

Researchers one step closer to finding treatment for dengue fever

Botanical Dietary Supplement Screening using NMR and MS

Catylix, Aspira Scientific partner to develop and commercialize new fluorination products

CardioNova initiates Phase 1b clinical trial with AtheroNova's AHRO-001

EMD Serono begins MSB0010718C Phase II study in mMCC patients

Researchers find molecule that irreversibly interferes with activity of mutated cancer gene

EMA CHMP adopts positive opinion for Janssen’s IMBRUVICA to treat CLL and MCL

Researchers one step closer to finding treatment for Alzheimer's, other forms of dementia

Cancer researchers find molecule that irreversibly interferes with KRAS gene

Enhancing confidence in chemical ionization spectrometry data eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News